Search Results - Stockerl‐Goldstein, Keith

Refine Results
  1. 1
    How to Screen for Monoclonal Gammopathy in Patients With a Suspected Amyloidosis

    How to Screen for Monoclonal Gammopathy in Patients With a Suspected Amyloidosis by Rubinstein, Samuel M., Stockerl-Goldstein, Keith

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury

    COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury by Crees, Zachary D., Stockerl-Goldstein, Keith

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis

    Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis by Zhang, Kathleen W., Stockerl-Goldstein, Keith E., Lenihan, Daniel J.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments

    COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments by Martínez, José Carlos, Sica, R. Alejandro, Stockerl-Goldstein, Keith, Rubinstein, Samuel M.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Retrospective comparison of allogeneic versus autologous transplantation for diffuse large B cell lymphoma with early relapse or primary induction failure

    Retrospective comparison of allogeneic versus autologous transplantation for diffuse large B cell lymphoma with early relapse or primary induction failure by Ghobadi, Armin, Nolley, Eric, Liu, Jingxia, McBride, Ali, Stockerl-Goldstein, Keith, Cashen, Amanda

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma

    GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma by Crees, Zachary D, Stockerl-Goldstein, Keith, Vainstein, Abi, Chen, Hemda, DiPersio, John F

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Remobilization of Hematopoietic Stem Cells in Healthy Donors for Allogeneic Transplantation

    Remobilization of Hematopoietic Stem Cells in Healthy Donors for Allogeneic Transplantation by Fiala, Mark A., Park, Soo, Slade, Michael, DiPersio, John F., Stockerl-Goldstein, Keith E.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome

    A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome by Wu, Peggy A., Kim, Youn H., Lavori, Phillip W., Hoppe, Richard T., Stockerl-Goldstein, Keith E.

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Secondary Acute Lymphoblastic Leukemia, a retrospective analysis from Washington University and meta-analysis of published data.

    Secondary Acute Lymphoblastic Leukemia, a retrospective analysis from Washington University and meta-analysis of published data. by Ferraro, Francesca, Gao, Feng, Stockerl-Goldstein, Keith, Westervelt, Peter, DiPersio, John F., Ghobadi, Armin

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Socioeconomic Status is Independently Associated with Overall Survival in Patients with Multiple Myeloma

    Socioeconomic Status is Independently Associated with Overall Survival in Patients with Multiple Myeloma by Fiala, Mark A., Finney, Joseph D., Liu, Jingxia, Stockerl-Goldstein, Keith E., Tomasson, Michael H., Vij, Ravi, Wildes, Tanya M.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Geriatric assessment in older adults with multiple myeloma

    Geriatric assessment in older adults with multiple myeloma by Wildes, Tanya M., Tuchman, Sascha A., Klepin, Heidi D., Mikhael, Joseph, Trinkaus, Kathryn, Stockerl-Goldstein, Keith, Vij, Ravi, Colditz, Graham

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    High dose therapy and autologous stem cell transplant in older adults with multiple myeloma

    High dose therapy and autologous stem cell transplant in older adults with multiple myeloma by Wildes, Tanya M, Finney, Joseph D, Fiala, Mark, Gao, Feng, Vij, Ravi, Stockerl-Goldstein, Keith, Carson, Kenneth R, Mikhael, Joseph, Colditz, Graham

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment

    An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment by Dimopoulos, Meletios A., Mikhael, Joseph, Terpos, Evangelos, Leleu, Xavier, Moreau, Philippe, Bladé, Joan, Kim, Jin Seok, Stockerl-Goldstein, Keith, Richardson, Paul G.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML

    Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML by Ramsingh, Giridharan, Westervelt, Peter, McBride, Ali, Stockerl-Goldstein, Keith, Vij, Ravi, Uy, Geoffrey, Cashen, Amanda, DiPersio, John F., Abboud, Camille N.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    A Phase I Study of the Safety and Feasibility of Bortezomib in Combination with G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma

    A Phase I Study of the Safety and Feasibility of Bortezomib in Combination with G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma by Ghobadi, Armin, Fiala, Mark A, Rettig, Michael, Schroeder, Mark, Uy, Geoffrey L., Stockerl-Goldstein, Keith, Westervelt, Peter, Vij, Ravi, DiPersio, John F

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    The Effect of Donor Type on Outcomes in Adults with Acute Myeloid Leukemia after Reduced Intensity Hematopoietic Peripheral Blood Cell Transplant

    The Effect of Donor Type on Outcomes in Adults with Acute Myeloid Leukemia after Reduced Intensity Hematopoietic Peripheral Blood Cell Transplant by Rashid, Nahid, Slade, Michael, Abboud, Ramzi, Gao, Feng, DiPersio, John F., Westervelt, Peter, Uy, Geoffrey, Stockerl-Goldstein, Keith, Romee, Rizwan, Schroeder, Mark A.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor

    Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor by Fadini, Gian Paolo, Fiala, Mark, Cappellari, Roberta, Danna, Marianna, Park, Soo, Poncina, Nicol, Menegazzo, Lisa, Albiero, Mattia, DiPersio, John, Stockerl-Goldstein, Keith, Avogaro, Angelo

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Fresh or Cryopreserved CD34(+)-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function following Allogeneic Hematopoietic Cell Transplantation

    Fresh or Cryopreserved CD34(+)-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function following Allogeneic Hematopoietic Cell Transp... by Ghobadi, Armin, Fiala, Mark A., Ramsingh, Giridharan, Gao, Feng, Abboud, Camille N., Stockerl-Goldstein, Keith, Uy, Geoffrey L., Grossman, Brenda J., Westervelt, Peter, DiPersio, John F.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study

    Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study by Jagannath, Sundar, Laubach, Jacob, Wong, Ellice, Stockerl‐Goldstein, Keith, Rosenbaum, Cara, Dhodapkar, Madhav, Jou, Ying‐Ming, Lynch, Mark, Robbins, Michael, Shelat, Suresh, Anderson, Kenneth C., Richardson, Paul G.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma

    A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma by Schroeder, Mark A., Fiala, Mark A., Huselton, Eric, Cardone, Michael H., Jaeger, Savina, Jean, Sae Rin, Shea, Kathryn, Ghobadi, Armin, Wildes, Tanya M., Stockerl-Goldstein, Keith E., Vij, Ravi

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: